Kiora Pharmaceuticals, Inc. (KPRX)
NASDAQ: KPRX · Real-Time Price · USD
2.665
+0.015 (0.57%)
At close: Sep 17, 2025, 4:00 PM EDT
2.650
-0.015 (-0.56%)
After-hours: Sep 17, 2025, 7:11 PM EDT
Kiora Pharmaceuticals Market Cap
Kiora Pharmaceuticals has a market cap or net worth of $9.15 million as of September 17, 2025. Its market cap has decreased by -16.82% in one year.
Market Cap
9.15M
Enterprise Value
-11.12M
1-Year Change
-16.82%
Ranking
Category
Stock Price
$2.67
Market Cap Chart
Since February 13, 2015, Kiora Pharmaceuticals's market cap has decreased from $38.90M to $9.15M, a decrease of -76.48%. That is a compound annual growth rate of -12.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 9.10M | -8.08% |
| Dec 31, 2024 | 9.90M | 147.50% |
| Dec 29, 2023 | 4.00M | 2.56% |
| Dec 30, 2022 | 3.90M | -79.58% |
| Dec 31, 2021 | 19.10M | -16.23% |
| Dec 31, 2020 | 22.80M | -37.36% |
| Dec 31, 2019 | 36.40M | 80.20% |
| Dec 31, 2018 | 20.20M | 9.78% |
| Dec 29, 2017 | 18.40M | 17.95% |
| Dec 30, 2016 | 15.60M | -25.71% |
| Dec 31, 2015 | 21.00M | -46.02% |
| Feb 13, 2015 | 38.90M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 686.51B |
| Johnson & Johnson | 424.98B |
| AbbVie | 382.04B |
| UnitedHealth Group | 307.73B |
| Novo Nordisk | 253.09B |
| AstraZeneca | 240.11B |
| Novartis AG | 237.94B |
| Abbott Laboratories | 231.06B |